Scientific Advisory Board
Scientific Advisory Board
The Scientific Advisory Board (SAB) of CurePSP, advises the Board of Directors on scientific and medical matters, assists with the educational and research activities of the organization, and reviews research grant applications/proposals on a semi-annual basis.
Voting members of the Scientific Advisory Board are prominent scientists and clinicians with expertise pertinent to PSP and CBD genetics, pathology, pathophysiology, clinical manifestations, and management.
Chair
Lawrence I. Golbe, MD
Robert Wood Johnson Medical School
New Brunswick, New Jersey
Lester I. Binder, PhD
Northwestern University, Feinberg School of Medicine
Chicago, Illinois
Ted M. Dawson, MD
Johns Hopkins University, School of Medicine
Baltimore, Maryland
Dennis W. Dickson, MD
Mayo Clinic
Jacksonville, Florida
Etienne C. Hirsch, PhD
French Institute of Health & Medical Research
Paris, France
Günter U. Höglinger, MD
Philipps University
Marburg, Germany
Virginia M.-Y. Lee, PhD
University of Pennsylvania, School of Medicine, Center for Neurodegenerative Disease Research
Philadelphia, Pennsylvania
Andrew J. Lees, MD, FRCP
UCL Institute of Neurology
London, United Kingdom
Irene Litvan, MD
University of California San Diego
San Diego, California
Christiane Richter-Landsberg, PhD
University of Oldenburg
Oldenburg, Germany
David E. Riley, MD
Case Western Reserve University, University Hospitals, Case Medical Center
Cleveland, Ohio
Gerard D. Schellenberg, PhD
University of Pennsylvania, School of Medicine
Philadelphia, Pennsylvania
David Williams, MBBS, PhD, FRACP
Monash University, Faculty of Medicine, Nursing and Health Sciences
Melbourne, Victoria, Australia
Richard Gordon Zyne, DMin, ex officio
President-CEO, CurePSP
